Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
3.875
-0.115 (-2.88%)
At close: Sep 25, 2026, 4:00 PM EDT
3.940
+0.065 (1.68%)
After-hours: Sep 25, 2026, 6:02 PM EDT
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $399.11 million as of September 25, 2026. Its market cap has increased by 348.06% in one year.
Market Cap
399.11M
Enterprise Value
265.00M
1-Year Change
348.06%
Ranking
Category
Stock Price
$3.88
ChartMarket Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $399.11M, a decrease of -50.52%. That is a compound annual growth rate of -11.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 399.11M | 67.02% |
| Dec 31, 2025 | 238.95M | 147.03% |
| Dec 31, 2024 | 96.73M | -70.04% |
| Dec 29, 2023 | 322.85M | 12.32% |
| Dec 30, 2022 | 287.43M | -50.22% |
| Dec 31, 2021 | 577.35M | -80.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rezolute | 409.10M |
| Relmada Therapeutics | 408.55M |
| YD Bio | 405.86M |
| ARS Pharmaceuticals | 405.75M |
| Scribe Therapeutics | 402.87M |
| Editas Medicine | 396.24M |
| Opus Genetics | 396.01M |
| Arcturus Therapeutics Holdings | 393.66M |